Patent · US Active

Salt form and crystal form of compound as FGFR4 inhibitor and preparation method thereof

US11440903B2 · kind B2 · utility

0Cited by

1References

26Claims

0Family size

Assignees

Inventors

Chaofeng Long · Tangxia, CN
Yang Zhang · San Diego, US
Zhengxia Chen · Shanghai, CN
Xiaoxin Chen · Cupertino, US
Zhuowei Liu · 流花街道, CN
Meibi Dai · Shanghai, CN
Zhiqiang Liu · Kyoto, JP
Shuhui CHEN · Shanghai, CN

Key dates

Filing date	Oct 30, 2018
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Jan 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The present invention provides a salt form, a crystal form, and a preparation method of a compound as an FGFR4 inhibitor and medical uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.